Global Ganja Report

British firm GW Pharmaceuticals has won "orphan drug status"—a special category for agents developed to treat rare diseases—from the US Food and Drug Administration (FDA) for Epidiolex, a derivative of cannabidiol (CBD), to treat Dravet syndrome, a severe form epilepsy. In Utah, parents who are lobbying to import CBD-rich cannabis strains from Colorado, say they will keep up their campaign. "This changes nothing" in regard to children being able to access CBD, said Jennifer May, mother of 11-year-old Stockton, who suffers from Dravet syndrome. "On the other hand, it does lend credibility to the potential of CBD as a treatment." Like many Dravet patients, Stockton has tried dozens of pharmaceutical fixes, and run out of options. He can no longer use the toilet and has to be fed from a tube. "Orphan drug" designation qualifies GW for tax credits and exclusive rights to the drug if approved. But FDA approval for Epidiolex could take a year or more. (Salt Lake Tribune, Nov. 18)

Hundreds of police officers, sheriffs' deputies and military servicemen from across the country—many donning battle fatigues—converged on downtown Oakland's Marriott Hotel Oct. 25 for the opening of the Urban Shield security confab and weapons show. National and international law enforcement agencies joined with defense industry contractors to attend seminars and display wares for three days. Outside the Marriott, scores of community activists protested the event. United under the name Facing Urban Shield, the coalition said the militarist tone of the event highlighted the worsening human rights records of police forces around the US, and the waste of billions of tax-dollars on prisons. They also charged that the showcasing of arms dealers undercut crime-plagued Oakland's efforts to stem gun violence.

The US Supreme Court on Oct. 7 rejected a challenge to the federal government's classification of cannabis as a Schedule I drug with no legitimate medical use. Challenger Americans for Safe Access contended that more than 200 studies have established that cannabis is safe and effective in relieving pain and nausea, and in relieving the effects of chemotherapy, among other medical uses. But federal courts have let stand the Drug Enforcement Administration's stance that the studies are insufficient.

It seems positively surreal that in the same USA where states like Colorado and Washington are legalizing cannabis, states like Louisiana are sending hapless souls up the river for possession of less than ounce—but this is indeed the case. New Orleans public interest attorney Bill Quigley in a Sept. 23 piece on the website Common Dreams notes the case of Corey Ladd, 27, a local man who on Sept. 24 was sentenced by a city criminal court to a full 20 years of "hard labor" at a state facility for holding 15 grams—that is, just slightly over half an ounce. 

Medical marijuana advocates Americans for Safe Access (ASA) will join the Brownie Mary Democratic Club of Riverside County to stage a peaceful counter-demonstration at 11 AM on Monday, Sept. 23, against the 2013 National Marijuana Policy & Strategy Conference being held in Rancho Cucamonga. The conference is sponsored by some of the same groups that have strenuously lobbied against statewide regulations in California, including the California Narcotic Officers' Association and the California Peace Officers' Association.

Before the 1988 GMC Thomas Built school bus was dubbed the "Cannabus" and made over with its marijuana-themed paint job, it was a red ski resort shuttle bus until two guys from North Carolina bought the bus in 2012 and set out on the "Green Bus Tour for Marijuana Legalization." The pair toured the East Coast for approximately nine weeks before certain events kept them from continuing, and the CannaBus went up for sale on eBay.

Deputy Attorney General James Cole, the same who authored a notorious 2011 memo asserting that federal cannabis enforcement remains a "core priority" even in states that have passed medical marijuana laws, has just issued a new memorandum seeming to clarify Justice Department reaction to the legalization measures in Colorado and Washington state. While it is written in the usual dense bureaucratese that often hides as much as it reveals, on balance it appears to represent a retreat from the hardline posture the Obama administration has assumed regarding medicinal cannabis over the past two years. The text of the Aug. 29 memo is provided by our comrades at CelebStoner:

Cannabis is a $1.65 billion industry in New York City, according to a report released Aug. 14 by comptroller and mayoral hopeful John Liu, with the potential to become a $1.7 billion industry if it were made legal in the Big Apple. The report is the first official estimate of the city's cannabis market, and the first study to consider the idea of legalization at the municipal level in the nation's biggest city.